The weight-loss revolution sparked by GLP-1 drugs like Ozempic and Mounjaro is doing more than changing waistlines – it’s transforming the food industry’s relationship with biology. As millions of ...

Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

In a world that chases fitness and wellness amidst the hustle of daily lives, weight loss jabs have become the magic pills ...

Novo Nordisk NVO is a dominant player in the cardiometabolic space, which markets its blockbuster semaglutide-based (GLP-1) ...

The nausea and other gastrointestinal side effects of weight loss drugs like Novo Nordisk’s Wegovy or Eli Lilly’s Zepbound will limit how much these drugs can help patients and stunt the overall ...

As Ozempic and Wegovy use increases so does the incidence of facial sagging, known as "Ozempic face." Now, brands are developing products specifically for these patients. Here's what you need to know.

MTVA READ THE FULL MTVA RESEARCH REPORT Business Update 8-Week Data for DA-1726 48 mg Cohort Expected in 4Q25 MetaVia, Inc.

New research reveals that popular GLP-1 medications like Ozempic could change how quickly alcohol affects the body, offering early clues into their surprising impact on craving, intoxication, and ...

Adults with atrial fibrillation with overweight or obesity were less likely to experience recurrent atrial arrhythmia when ...

Discover why Hims & Hers Health (HIMS) remains a strong long-term buy after robust Q3 growth, new offerings, and expansion ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

The MarketWatch News Department was not involved in the creation of this content. DUBLIN and BRIDGEWATER, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company ...